Skip to main content
logo
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.8650
-0.0060 (-0.69%)
At close: Oct 2, 2026, 4:00 PM EDT
0.8719
+0.0069 (0.80%)
After-hours: Oct 2, 2026, 7:35 PM EDT

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $49.13M in the quarter ending June 30, 2026, a decrease of -21.36%. This brings the company's revenue in the last twelve months to $219.06M, up 7.52% year-over-year. In the year 2025, Akebia Therapeutics had annual revenue of $236.20M with 47.46% growth.

Revenue (ttm)
$219.06M
Revenue Growth
+7.52%
P/S Ratio
1.09
Revenue / Employee
$1,129,175
Employees
194
Market Cap
239.70M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025236.20M76.02M47.46%
Dec 31, 2024160.18M-34.44M-17.70%
Dec 31, 2023194.62M-97.86M-33.46%
Dec 31, 2022292.48M80.83M38.19%
Dec 31, 2021211.65M-82.99M-28.17%
Dec 31, 2020294.64M-40.36M-12.05%
Dec 31, 2019335.00M127.26M61.26%
Dec 31, 2018207.74M26.52M14.63%
Dec 31, 2017181.23M179.69M11,706.32%
Dec 31, 20161.54M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Emergent BioSolutions770.20M
Organogenesis Holdings457.45M
Aurora Cannabis221.16M
Organigram Global217.71M
Canopy Growth206.77M
Lifecore Biomedical129.46M
Anika Therapeutics120.65M
Journey Medical68.18M
Revenue Rankings

AKBA News

More News